Literature DB >> 32042623

Neoadjuvant chemotherapy in bladder cancer: not a matter on how much but on who it is effective.

Giovanni Motterle1, R Jeffrey Karnes1.   

Abstract

Entities:  

Year:  2019        PMID: 32042623      PMCID: PMC6989860          DOI: 10.21037/tau.2019.09.39

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN: 2223-4683


× No keyword cloud information.
  10 in total

1.  Bladder cancer: Conditional survival after radical cystectomy.

Authors:  Giorgio Gandaglia; Maxine Sun
Journal:  Nat Rev Urol       Date:  2013-12-17       Impact factor: 14.432

Review 2.  The evolution of bladder cancer genomics: What have we learned and how can we use it?

Authors:  François Audenet; Kyrollis Attalla; John P Sfakianos
Journal:  Urol Oncol       Date:  2018-03-21       Impact factor: 3.498

3.  Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer.

Authors:  Robert Rosenblatt; Amir Sherif; Erkki Rintala; Rolf Wahlqvist; Anders Ullén; Sten Nilsson; Per-Uno Malmström
Journal:  Eur Urol       Date:  2011-12-13       Impact factor: 20.096

4.  Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy.

Authors:  Maxine Sun; Firas Abdollah; Marco Bianchi; Quoc-Dien Trinh; Shahrokh F Shariat; Claudio Jeldres; Zhe Tian; Jens Hansen; Alberto Briganti; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Journal:  Eur J Cancer       Date:  2011-12-21       Impact factor: 9.162

5.  Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides.

Authors:  Zachary D Reardon; Sanjay G Patel; Harras B Zaid; C J Stimson; Matthew J Resnick; Kirk A Keegan; Daniel A Barocas; Sam S Chang; Michael S Cookson
Journal:  Eur Urol       Date:  2014-01-23       Impact factor: 20.096

6.  Perioperative treatment and radical cystectomy for bladder cancer--a population based trend analysis of 10,338 patients in the Netherlands.

Authors:  Tom J N Hermans; Elisabeth E Fransen van de Putte; Simon Horenblas; Valery Lemmens; Katja Aben; Michiel S van der Heijden; Laurens V Beerepoot; Rob H Verhoeven; Bas W G van Rhijn
Journal:  Eur J Cancer       Date:  2015-12-18       Impact factor: 9.162

7.  Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.

Authors:  A Gordon Robertson; Jaegil Kim; Hikmat Al-Ahmadie; Joaquim Bellmunt; Guangwu Guo; Andrew D Cherniack; Toshinori Hinoue; Peter W Laird; Katherine A Hoadley; Rehan Akbani; Mauro A A Castro; Ewan A Gibb; Rupa S Kanchi; Dmitry A Gordenin; Sachet A Shukla; Francisco Sanchez-Vega; Donna E Hansel; Bogdan A Czerniak; Victor E Reuter; Xiaoping Su; Benilton de Sa Carvalho; Vinicius S Chagas; Karen L Mungall; Sara Sadeghi; Chandra Sekhar Pedamallu; Yiling Lu; Leszek J Klimczak; Jiexin Zhang; Caleb Choo; Akinyemi I Ojesina; Susan Bullman; Kristen M Leraas; Tara M Lichtenberg; Catherine J Wu; Nicholaus Schultz; Gad Getz; Matthew Meyerson; Gordon B Mills; David J McConkey; John N Weinstein; David J Kwiatkowski; Seth P Lerner
Journal:  Cell       Date:  2017-10-05       Impact factor: 41.582

8.  Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time.

Authors:  Guillaume Ploussard; Shahrokh F Shariat; Alice Dragomir; Luis A Kluth; Evanguelos Xylinas; Alexandra Masson-Lecomte; Malte Rieken; Michael Rink; Kazumasa Matsumoto; Eiji Kikuchi; Tobias Klatte; Stephen A Boorjian; Yair Lotan; Florian Roghmann; Adrian S Fairey; Yves Fradet; Peter C Black; Ricardo Rendon; Jonathan Izawa; Wassim Kassouf
Journal:  Eur Urol       Date:  2013-10-09       Impact factor: 20.096

9.  The impact of pathologic response to neoadjuvant chemotherapy on conditional survival among patients with muscle-invasive bladder cancer.

Authors:  Nikhil Waingankar; Rachel Jia; Kathryn E Marqueen; Francois Audenet; John P Sfakianos; Reza Mehrazin; Bart S Ferket; Madhu Mazumdar; Matthew D Galsky
Journal:  Urol Oncol       Date:  2019-05-18       Impact factor: 2.954

10.  Comprehensive molecular characterization of urothelial bladder carcinoma.

Authors: 
Journal:  Nature       Date:  2014-01-29       Impact factor: 49.962

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.